CoChat

Nicotinamide Mononucleotide, an NAD+ Precursor, Rescues Age-Associated Susceptibility to AKI in a Sirtuin 1–Dependent Manner

Open access
Guan, Yi, Wang, Su-Rong, Huang, Xin-Zhong, Xie, Qiong-hong, Xu, Yun-Yu, Shang, Da, Hao, Chuan-Ming · 2017 · Journal of the American Society of Nephrology

The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.

Abstract

The rapid growth of an aging population creates challenges regarding age-related diseases, including AKI, for which both the prevalence and death rate increase with age. The molecular mechanism by which the aged kidney becomes more susceptible to acute injury has not been completely elucidated. In this study, we found that, compared with the kidneys of 3-month-old mice, the kidneys of 20-month-old mice expressed reduced levels of the renal protective molecule sirtuin 1 (SIRT1) and its cofactor NAD + . Supplementation with nicotinamide mononucleotide (NMN), an NAD + precursor, restored renal SIRT1 activity and NAD + content in 20-month-old mice and further increased both in 3-month-old mice. Moreover, supplementation with NMN significantly protected mice in both age groups from cisplatin-induced AKI. SIRT1 deficiency blunted the protective effect of NMN, and microarray data revealed that c-Jun N-terminal kinase (JNK) signaling activation associated with renal injury in SIRT1 heterozygotes. In vitro , SIRT1 attenuated the stress response by modulating the JNK signaling pathway, probably via the deacetylation of a JNK phosphatase, DUSP16. Taken together, our findings reveal SIRT1 as a crucial mediator in the renal aging process. Furthermore, manipulation of SIRT1 activity by NMN seems to be a potential pharmaceutical intervention for AKI that could contribute to the precise treatment of aged patients with AKI.

Overview

Integrity signals

Registry

Crossref · 10.1681/asn.2016040385

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 53 references

Cited by

See all 238

Metadata

Authors
Guan, Y., Wang, S.-R., Huang, X.-Z., Xie, Q.-H., Xu, Y.-Y., Shang, D., & Hao, C.-M.
Affiliations
Fudan University (CN)
Corresponding author
  • Shang, Da
  • Hao, Chuan-Ming
Venue
Journal of the American Society of Nephrology
Published
2017-02-28
Volume
28
Issue
8
Pages
2337-2352
ISSN
  • 1046-6673 (ISSN-L)
  • 1533-3450
OpenAlex
W2592892973
Cited by
238
References
53
Citations by year
2026: 18 · 2025: 24 · 2024: 28 · 2023: 28 · 2022: 40 · 2021: 38 · 2020: 26 · 2019: 20 · 2018: 8 · 2017: 8
FWCI
10.25
Type
journal article
Language
en
Open access
Locations
  • Journal of the American Society of Nephrology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Natural Science Foundation of China
  • Chinese Academy of Sciences
  • Fudan University
  • National Key Research and Development Program of China
Topics
  • Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
  • Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Chemotherapy-induced organ toxicity mitigation
Keywords
nicotinamide mononucleotide, NAD+ precursors, SIRT1, acute kidney injury, kidney aging, cisplatin nephrotoxicity, JNK signaling, DUSP16, NAD+ depletion, renal protection
MeSH terms
Age Factors, Animals, Disease Susceptibility, NAD, Nicotinamide Mononucleotide, JNK Mitogen-Activated Protein Kinases, Mice, Sirtuin 1, Acute Kidney Injury

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Nicotinamide Mononucleotide, an NAD+ Precursor, Rescues Age-Associated Susceptibility to AKI in a Sirtuin 1–Dependent Manner. https://app.cochat.ai/papers/10.1681/asn.2016040385
The paper
Guan, Y., Wang, S.-R., Huang, X.-Z., Xie, Q.-H., Xu, Y.-Y., Shang, D., & Hao, C.-M. (2017). Nicotinamide Mononucleotide, an NAD+ Precursor, Rescues Age-Associated Susceptibility to AKI in a Sirtuin 1–Dependent Manner. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.2016040385

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.